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INTRODUCTION
Neural progenitor cells (NPCs) are promising candidates for 
cell transplantation to treat pathophysiological conditions of the 
central nervous system (CNS) such as Alzheimer disease, multiple 
sclerosis, hypoxic ischemic encephalopathy, and ischemic stroke 
[1-6]. However, the clinical application of stem cell technology 
faces several technical and safety challenges, particularly heteroge-
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neity, poor neuronal yield, and low survival rate. Neurodegenera-
tive diseases—including ischemic stroke—are characterized by 
irreversible tissue damage resulting from hemodynamic, cellular, 
and molecular changes [7, 8], which affect both the resident cells 
and the therapeutically transplanted NPCs. One of the prominent 
molecular changes accompanying neurodegenerative diseases is 
an increase in the level of reactive oxygen species (ROS), which 
causes the oxidization of cellular components, excessive calcium 
influx, the breakdown of mitochondrial membrane potential, 
and cell death [8, 9]. Recently, it has become clear that balanced 
regulation of ROS is of critical significance for cell fate determina-
tion as well as for stem cell differentiation, function, and survival 
following transplantation in injured tissues [10]. Therefore, the 
development of advanced cell replacement therapies for neuro-
degenerative diseases is required, and the development of robust 
NPCs capable of surviving in injured environments is essential. 
Agmatine (NH2[CH2]4NH2C[NH]=NH; PubChem CID: 199), the 
natural metabolite of arginine, interacts with several intracellular 
molecular targets before being exported out of the cell [11], and 
modulates neuronal functions in in vitro and in vivo neuronal in-
jury models [11-16]. Recently, Battaglia et al. showed that agmatine 
plays a key role in preventing Ca2+-induced mitochondrial perme-
ability transition (mPT) and membrane potential collapse [12, 13]. 
Moreover, we have previously reported that agmatine and arginine 
decarboxylase (ADC) provide neuroprotection against various 
CNS injuries by scavenging ROS, attenuating inflammatory sig-
naling and apoptosis [14-19]. In previous studies, we constructed 
NPCs that overexpressed ADC genes (ADC-NPCs) using a ret-
roviral vector system [20], and showed that an excess of agmatine 
was endogenously produced in the ADC-NPCs; this endogenous 
agmatine protected the NPCs from hydrogen peroxide (H2O2) 
injury [14]. However, these studies did not investigate the mecha-
nism by which endogenously produced agmatine protects cells 
from ADC-NPCs. In the present study, we attempted to determine 
how the cell cycle and neurogenesis are regulated in NPCs over-
expressing ADC genes during ischemic stress. We also determined 
whether transplanted ADC-NPCs can resist severe pathophysi-
ological insult, and have the potential for neural differentiation, 
synapse formation, and neurological functional recovery following 
ischemic stroke in rats. In the present study, we attempted to eluci-
date the mechanism by which ADC-NPCs provide neuroprotec-
tion. Our results suggest that the altered expression of arginine 
decarboxylase in transplant ADC-NPCs could form the basis of 
an alternative therapy for ischemic brain injury.
MATERIALS AND METHODS
Experimental animals
For the in vitro experiment, we collected primary NPCs from the 
offspring of E14.5 pregnant imprinting control region (ICR) mice 
weighing 35~40 g (Koatech Technology Corp., Republic of Korea). 
We used 8-week-old Sprague Dawley rats weighing 280~300 g 
(Samtaco Co., Ltd., Osan, Republic of Korea) for the in vivo experi-
ments. All animal procedures were carried out according to the 
protocol approved by the International Animal Care and Use Com-
mittee (IACUC) of the Yonsei University Animal Research Center 
(YLARC, permission No. 2014-0286) following National Institutes 
of Health guidelines. All animals were maintained in a specific 
pathogen-free facility at the YLARC under controlled temperature 
(23oC) and light cycle (12 h light and 12 h dark) conditions with ad 
libitum access to water and food.
Isolation and culture of mouse striatum-derived neural 
stem/progenitor cells
We cultured the NPCs as described previously [15]. Briefly, we 
extracted E14.5 embryos (Koatech Technology Corp., Republic 
of Korea) from placental tissue under a surgical microscope using 
surgical kits. The striatum was removed from the fetal brain and 
placed in Hank’s balanced salt solution (HBSS; Thermo Scientific, 
USA). The dissected tissues were allowed to settle for 3 min, then 
centrifuged at 8×g for 5 min. The tissue pellets were gently triturat-
ed by repeated passage through a fire-polished, constricted Pasteur 
pipette in murine NeuroCultTM NSC basal medium containing a 
proliferation supplement (Stem Cell Technologies, USA) and 20 
ng/ml epidermal growth factor (EGF) (Invitrogen, USA). The cells 
were counted and plated into T25 flasks at a density of 2.5~3×106 
cells/10 ml. The culture flasks were incubated in a humidified 
atmosphere comprising 95% air and 5% CO2 at 37
oC. We replaced 
the culture media every 3 days. We used the striatal NPCs for the 
in vitro and in vivo experiments after 7 days.
Construction of retroviral pLXSN vector containing the re-
combinant human ADC gene, and cellular transfection
The full-length human arginine decarboxylase (ADC) gene 
complementary DNA (cDNA) (GenBank accession number: 
AY325129.1) was constructed as described previously [14-16, 
20]. We filtered the highest titer of retrovirus-containing medium 
(v LXSN vector carrying the human ADC gene, vh ADC; 1×105 
colony-forming units (CFU)/ml) through a 0.45-μm polysulfone 
filter (Sartorius Stedim Biotech) to infect the NPCs at days in vitro 
6 (DIV6) for 24 h, then subjected them to 2 h of oxygen–glucose 
deprivation (OGD).
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Oxygen–glucose deprivation (OGD)
OGD was applied as previously described [21, 22]. Briefly, the 
NSC media were replaced with filtered, deoxygenated, glucose-free 
Eagle’s balanced salt solution (BSS0.0). The NPCs were placed in an 
anaerobic chamber (Coy Laboratories, Grass Lake, MI, USA) con-
taining a gas mixture comprising 5% CO2, 5% H2, and 85% N2 (0.2% 
O2) under glucose-free anaerobic conditions at 37
oC for 2 h. OGD 
was terminated by returning the cells to normoxic conditions in 
normal NSC (proliferation) medium containing a proliferation 
supplement and 20 ng/ml EGF.
Cell cycle determination using flow cytometry analysis
We harvested the NPCs by centrifugation (12,000×g  at 4oC) 
for 20 min to determine the cell cycle phase using fluorescence-
activated cell sorting (FACS) analysis at DIV7 under both normal 
and OGD conditions. We placed the collected cells in HBSS with-
out Ca2+, Mg2+, or phenol red (HyClone, USA), and washed them 
prior to single-cell dissociation for 15 min at 37oC. We then gently 
resuspended the cells using a NeuroCultTM chemical dissociation 
kit (Stem cell Technologies, 05707) according to the manufactur-
er’s instructions. We rinsed the cell suspension (~1×106 cells/ml) 
in HBSS and fixed the cells in 1.1 ml of 100% ethanol and 0.4 ml 
of 100% fetal bovine serum, which we added dropwise for single 
cell fixation while gently vortexing. We maintained the fixed cells 
at -20oC overnight, then washed them once in phosphate-buffered 
saline (PBS) and centrifuged them at 1,680 rpm for 5 min. We 
transferred the resulting pellets to a BD Biosciences FACS tube 
containing ice-cold PBS, added 100 μl of 1 mg/ml RNase A (bio-
WORLD, Republic of Korea), and left the mixture for 20 min at 
25oC. We then incubated the cells in a staining solution containing 
1 μg/ml propidium iodide (PI; Sigma, P4170, USA) at room tem-
perature for 5 min. We investigated the cells using BD Biosciences 
LSRII FACS software after acquiring at least 20,000 events, as-
sessed the cells using a BD Biosciences LSRII FACS flow cytome-
try system. To achieve accurate results, plots were excluding debris 
and non-viable cells in the gating strategy. Results were analyzed 
using FlowJo software, first gate on the single cell population using 
pulse width vs. pulse area. Then apply this gate to the scatter plot 
and gate out obvious debris. Combine the gates and apply to the PI 
histogram plot.
Western blot analysis
We performed western blot analysis using equal amounts of 
protein (15 mg) of whole-cell, cytoplasmic, and nuclear extraction 
(NE-PER 78835, Thermo Scientific, USA), and striatal tissue ly-
sates prepared from the indicated groups, as described previously 
[15]. We blocked the membranes for 1 h at room temperature 
with 5% skim milk or bovine serum albumin in 1×Tris-buffered 
saline (TBS) and 0.1% Tween-20 (TBST). We incubated the 
membranes overnight at 4oC with the following primary antibod-
ies: anti-arginine decarboxylase (ADC) (ADC, 1:500; ATGEN), 
anti-doublecortin (DCX) (AB23542, 1:1000; ABCAM), anti-
GFAP (MS1376, 1:200; Thermo Scientific), anti-Olig2 (AB81093, 
1:1000; ABCAM), anti-cyclin-dependent kinase 4 (CDK4) 
(SC601, 1:1000; Santa Cruz), anti-phospho-retinoblastoma pro-
tein (p-pRB Ser 807/811) (#9308, 1:1000; Cell Signaling), anti-
retinoblastoma protein (pRB) (SC50, 1:1000; Santa Cruz), anti-
E2F1 (SC193, 1:1000; Santa Cruz), anti-phospho-p44/42 MAPK 
(pERK1/2 Thr202/Tyr204) (#9101, 1:1000; Cell Signaling), anti-
p44/42 MAPK (ERK1/2) (#9102, 1:1000; Cell Signaling), anti-
phospho-CREB (pCREB Ser133) (#9198, 1:1000; Cell Signaling), 
anti-CREB (#9197, 1:1000, Cell Signaling), anti-phospho-STAT1 
(pSTAT1 Ser727) (#9177, 1:1000; Cell Signaling), anti-STAT1 
(#9172, 1:1000; Cell Signaling), anti-synaptophysin (MAB368, 
1:1000; Millipore), anti-GAP43 (#8945, 1:1000; Cell Signaling), 
anti-PSD95 (AB18258, 1:1000; ABCAM), anti-neurofilament 
(04-1032, 1:1000; Millipore), anti-beta-actin (AB8226, 1:1000; 
ABCAM), and anti-lamin-B1 (SC6217, 1:1000; Santa Cruz). We 
washed the membranes three times with TBST every 10 mins, and 
incubated them with secondary antibodies conjugated to horse-
radish peroxidase in TBST for 1 h at room temperature. Finally, 
we rinsed the membranes and visualized the proteins using a 
SuperSignal West Pico Chemiluminescent Substrate protein de-
tection kit according to the manufacturer’s instructions. We visual-
ized the blots using LAS 4000 mini image analysis software (GE 
Healthcare, Buckinghamshire, UK), and carried out densitometric 
measurements on all the detected proteins using Image J.
Immunocytochemistry and immunohistochemistry
We carried out immunochemistry with the indicated groups as 
previously described [15]. We washed the NPCs and brain tissues 
three times with PBS, fixed them with 4% paraformaldehyde for 3 
h, and washed them again with PBS. We permeabilized the NPCs 
with PBS containing 0.025% Triton X-100 (PBST), and blocked 
them for 1 h at room temperature with goat-blocking serum (In-
vitrogen) or 1% bovine serum albumin in PBS. We incubated the 
NPCs overnight at 4oC with the following primary antibodies in 
antibody diluent solution (Invitrogen): anti-arginine decarboxyl-
ase (ADC) (ADC, 1:200; ATGEN), anti-agmatine (AB1568, 1:200; 
Chemicon), anti-nestin (MAB353, 1:200; Millipore), anti-double-
cortin (DCX) (AB23542, 1:200; ABCAM), anti-S100β (AB52642, 
1:200; ABCAM), anti-GFAP (MS1376, 1:200; Thermo Scientific), 
anti-Olig2 (AB81093, 1:200; ABCAM), anti-myelin basic protein 
(MBP) (AB7349, 1:200; ABCAM), anti-cyclin-dependent kinase 4 
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(CDK4) (SC601, 1:200; Santa Cruz), anti-phospho-retinoblastoma 
protein (p-pRB Ser 807/811) (#9308, 1:200; Cell Signaling), anti-
retinoblastoma protein (pRB) (SC50, 1:200; Santa Cruz), anti-
E2F1 (SC193, 1:200; Santa Cruz), anti-phospho-p44/42 MAPK 
(pERK1/2 Thr202/Tyr204) (#9101, 1:200; Cell Signaling), anti-
phospho-CREB (pCREB Ser133) (#9198, 1:200; Cell Signaling), 
anti-phospho-STAT1 (pSTAT1 Ser727) (#9177, 1:200; Cell Signal-
ing), anti-MAP2 (AB5392, 1:200; ABCAM), anti-synaptophysin 
(MAB368, 1:200; Millipore), and anti-PSD95 (AB18258, 1:200; 
ABCAM). We removed the primary antibodies and washed the 
NPCs three times for 3 min each time with PBST. We then incu-
bated the samples with the appropriate secondary antibodies con-
jugated to FITC, rhodamine, and Alexa Fluor® 405 prepared in 
fluorescent antibody diluent solution (1:200~1:500; ABCAM) for 
2 h at room temperature. We washed the NPCs again three times 
for 3 mins each time with PBST. Finally, we counterstained the 
NPCs with 4ʹ,6-diamidino-2-phenylindole (DAPI) and visualized 
them using an LSM 710 confocal microscope.
Small interfering RNA (siRNA) transfection in NPCs
Double-stranded siRNAs (21-mer, AccuTargetTM genome-wide 
predesigned siRNAs) targeting hADC were designed and synthe-
sized by Bioneer (Alameda, CA, USA). The corresponding target 
mRNA sequences for the siRNAs were as follows: si-hADC-sense, 
5ʹ-CUCCAAGACCAUCGUGUAC-3ʹ; si-h ADC-antisense, 
5ʹ-GUACACGAUGGUCUUGGAG-3ʹ; and AccuTarget TM nega-
tive control siRNA (SN-1002, Bioneer). The nucleotides targeted 
h ADC mRNA sequences (accession number: NM_052998). We 
cultured the ADC-NPCs (2×106 cells/10 ml) in a T-25 flask in mu-
rine NeuroCultTM medium containing a proliferation supplement 
and 20 ng/ml EGF. After ADC infection, we transfected the ADC-
NPCs with siRNA at 60~80% confluence, according to the manu-
facturer’s protocol. Briefly, we diluted the hADC siRNA oligomers 
in serum-free Opti-MEM® medium (Invitrogen) and mixed them 
with Lipofectamine RNAiMAX reagent (Invitrogen) prediluted in 
Opti-MEM®. After a 5-min incubation at room temperature, we 
added the complexes (final concentration 10 nM per T-25 flask) 
to the cells. The cells were transfected for 72 h. We used AccuTar-
get TM siRNAs as negative controls [23].
Determination of intracellular Ca2+ levels in NPCs
We chemically dissociated the NPCs into single cells and at-
tached them to a glass bottom dish (SPL, Republic of Korea) 
coated with poly-L-ornithine (P4957, Sigma) for 1 h. NPCs were 
loaded with the Ca2+-sensitive green fluorescence indicator Fluo-4 
AM (4 μM, F14217; Molecular Probes®) diluted in Tyrode’s buf-
fer (2Ca5K solution (319 mOsm) containing 2 mM CaCl2, 1 mM 
MgCl2, 140 mM NaCl, 5 mM KCl, 10 mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES) buffer (pH 7.4, Sigma), 
10 mM glucose, and 0.5 M ethylenediaminetetraacetic acid 
(EDTA) at 37oC for 30 min. We prepared zero-calcium solutions 
by replacing CaCl2 with equimolar MgCl2 and 0.5 mM EDTA 
[24]. We examined the Fluo-4AM-labeled Ca2+ using an LSM 710 
confocal microscope. The Fluo-4AM signal was recorded every 3 
sec for 5 min, and the signal intensity (region of interest; ROI) was 
calculated using ZEN 2011 measurement software. The Fluo-4AM 





Where kd is the dissociation constant of the indicator (Fluo-4AM; 
345 nM).
Measurement of oxygen consumption rate
We used a Seahorse XF24 Extracellular Flux Analyzer (Seahorse 
Biosciences; North Billerica, MA, USA) to measure the oxygen 
consumption rate (OCR) in the cells. We seeded the dissociated 
NPCs onto 24-well Seahorse microplates at a density of 1.5×105 
cells per well. Before taking the measurements, we soaked the sen-
sor cartridges in XF Calibrant Solution (Seahorse Biosciences) in 
24-well cell culture microplates overnight at 37oC to hydrate them. 
We filled the injection ports on the sensor cartridge with drugs 
from an XF Cell Mito Stress Test Kit (Seahorse Bioscience): oligo-
mycin (1 μM), carbonyl cyanide 4-(trifluoromethoxy) phenylhy-
drazone (FCCP) (1 μM), and rotenone (1 μM) with antimycin A 
(1 μM). The XF24 microplate was loaded into the Seahorse XF24 
analyzer according to the manufacturer’s instructions. All experi-
ments were carried out at 37oC.
Animal model of cerebral ischemia
We carried out transient middle cerebral artery occlusion (tM-
CAO) as previously described [18]. In brief, we intramuscularly 
anesthetized Sprague Dawley rats with Zoletil 50 (0.6 mg/kg; Vir-
bac) and Rompun (0.4 mg/kg). We monitored the body tempera-
tures of the animals with a rectal probe and ensured they remained 
at between 36.5oC and 37.5oC using heating pads. We anesthetized 
all the experimental animals before surgery. We then exposed the 
right common carotid artery (rCCA), the external carotid artery 
(ECA), and the internal carotid artery (ICA) of each rat through 
a ventral midline incision. We introduced a 4–0 monofilament 
nylon suture into the CCA lumen of each rat and gently advanced 
through the ICA to the MCA until the regional cerebral blood 
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flow was reduced to 15~20% of baseline as monitored by a laser 
Doppler flow meter (OMEGA FLOW, FLO-C1, Neuroscience, 
Tokyo, Japan). After 1 h of occlusion, we withdrew the suture to 
restore blood flow. We kept the animals on the heating pad and al-
lowed them ad libitum access to food and water.
ADC-NPCs transplantation
We transplanted the ADC-NPCs (1×106 cells/10 μl) into the ip-
silateral striatum (posterior +0.3 mm, lateral 3 mm, ventral 5 mm 
from bregma) using a 25 G Hamilton syringe 7 days after MCAO 
using a stereotaxic apparatus. After cell transplantation, we placed 
the needle into the injection site over a 10 min period to inhibit 
backflow.
Morphometric measurement of infarct volume by hema-
toxylin and eosin (H&E) staining
We decapitated the rats after ischemia, and rapidly removed 
the brains and coronal sections obtained at 2-mm intervals. We 
measured the volume of the infarction in each animal as the slice 
thickness (2 mm), and calculated the sum of the infarction areas in 
all the brain slices. The brain infarct volume was determined using 
the following formula: brain infarct volume (%)=(the volume of 
the ipsilateral hemisphere/the volume of the contralateral hemi-
sphere)×100.
Behavior test
After MCAO, we assessed the behavior of each rat using the ro-
tarod test to detect improvements in neurological motor function. 
We increased the rotarod (Med Associates Inc.) speed from 4 to 
40 rpm. We tested the rats five times on each testing day allowing 
them a minimum of 5 min rest in the home cage between trials.
Colocalization image analysis
We performed automatic colocalization assays for the fluores-
cence images using the Pearson’s correlation coefficient (PCC) 
and Manders’ overlap coefficients (MOCs) K1 & K2 using the 
JACoP plugin for ImageJ [26-29]. Briefly, the Pearson’s coefficient 
provides an estimate of the goodness of fit and the rate of associa-
tion between two fluorochromes. Its value can range from 1 to -1: 
1 represents complete positive correlation; -1 represents negative 
correlation; 0 represents no correlation; 0.8≥r≥0.5 indicates a 
moderate positive value of colocalization; and 0.5≥r≥0 indicates a 
weak positive value of colocalization. In the present study, the PCC 
represented the value of colocalization in the nucleus, analyzed 
using a specific antigen (channel 1) and DAPI (channel 2). The 
MOC is calculated as the Pearson’s coefficient with the mean in-
tensity value of both channels taken out of the expression; its value 
is defined as between 0 and 1. Two additional overlap coefficients, 
K1 & K2, were used to split the mean value of colocalization: the 
former is related to the first channel total intensity, the latter is 
related to the second channel total intensity. In the present study, 
MOC K1 & K2 are represented as the single fluorescence intensity 
in the merged figure, analyzed with a specific antigen (channel 1: 
K1 and channel 2: K1+K2). To determine the single fluorescence 
intensity in the merged figure, all MOC graphs represent the K1 
value.
Statistical analysis
We carried out statistical tests to determine differences between 
groups using the Student’s t -test, and compared the data at each 
time-point by one-way analysis of variance (ANOVA; Tukey hon-
est significant difference test) using the VassarStats website. p<0.05 
and p<0.01 were considered significant. The data are expressed as 
the mean±standard error of the mean (SEM).
RESULTS
ADC-NPCs resist cell death and promote neural differen-
tiation following ischemic stress
We subjected the ADC-NPCs to OGD for 2 h following isch-
emic stress to investigate their therapeutic potential. ADC protein 
and agmatine levels both increased significantly in the ADC-
NPCs under normal and OGD conditions, but the expression 
of ADC protein was higher under OGD conditions than under 
normal conditions (Fig. 1A and 1B). During ischemic stress, ADC 
protein was also expressed in the wild-type NPCs (wt-NPCs), 
but the expression level was lower than in the ADC-NPCs (Fig. 
1A and 1B). The number of PI-positive ADC-NPCs decreased 
significantly following OGD (Fig. 1C and 1D). To identify cell 
cycle regulation in the wt-NPCs and ADC-NPCs, we subjected 
the PI-stained cells to flow cytometry at DIV7 under both normal 
and OGD conditions. The FACS results indicated that ADC-
NPCs significantly reduced the cell population of G0-G1 phase 
(77.31±2.21% of wt-NPCs vs. 61.68±5.93% of ADC-NPCs) and 
extended the cell population of G2-M phase (19.17±2.12% of wt-
NPCs vs. 34.31±5.47% of ADC-NPCs) following normal condi-
tion. In contrast, ADC-NPCs significantly extended the cell popu-
lation of G0-G1 phase (74.54±1.3% of wt-NPCs vs. 82.25±0.9% 
of ADC-NPCs) following OGD, suggesting that the ADC-NPCs 
induced a shift in the cell cycle from proliferation to quiescence/
differentiation in the G0-G1 phase following OGD injury (Fig. 
1E). These results indicate that ADC and agmatine overexpression 
in ADC-NPCs attenuate cell death and cell cycle exit following 
ischemic stress. It has been reported that NPCs differentiate into 
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different neuronal cells in a suitable environment. With this view 
to investigating the neural differentiation of ADC-NPCs during 
ischemic stress, we investigated the expression levels of various 
proteins in ADC-NPCs subjected to OGD. Both western blot and 
immunostaining analyses revealed that the expression levels of 
neuronal marker DCX, astroglial marker GFAP, and oligoden-
droglial marker Olig2 increased in the ADC-NPCs under normal 
conditions (Fig. 2A~2E). However, the expression levels of DCX 
and Olig2 were four times greater in the ADC-NPCs than in the 
normal NPCs following OGD injury, and the expression of GFAP 
was significantly lower in the ADC-NPCs after the same insult 
(Fig. 2A~2C and 2E). These results suggest that the overexpression 
of ADC genes in NPCs attenuates cell death, cell cycle exit, and 
enhanced neural differentiation following ischemic stress.
ADC-NPCs promote cell cycle arrest by aberrant nucleocyto-
plasmic shuttling of p-pRB and E2F1 following ischemic stress
Cell cycle progression is an important determinant of the de-
velopmental process. Cellular differentiation in multicellular 
organisms can be initiated through cell cycle withdrawal via tran-
scriptional regulation [30]. To identify cell cycle regulation in the 
wt-NPCs and ADC-NPCs, we investigated some of the essential 
components of the G1-S phase transition in eukaryotic cells, 
i.e., CDK4/2, pRB, p-pRB, and E2F1/DP-1. The CDK4 complex 
Fig. 1. Neural progenitor cells (NPCs) overexpressing arginine decarboxylase (ADC) genes (ADC-NPCs) attenuate cell death and cell cycle exit fol-
lowing ischemic stress. (A) Western blot of NPCs and (B) quantification graph indicating that the expression level of ADC in the ADC-NPCs increased 
under both normal and oxygen–glucose deprivation (OGD) conditions (n=3~4 per condition). (C) Immunocytochemical staining of ADC and agma-
tine, and Hoechst 33342 (Hxt33342)–propidium iodide (PI) staining in NPCs under both normal and OGD conditions. (D) Quantification graph of 
Hxt33342-PI staining in NPCs under both normal and OGD conditions. Overexpression in ADC-NPCs increases the number of PI-positive dead cells. 
(E) Fluorescence-activated cell sorting (FACS) analysis of PI-positive NPCs shows the cell cycle states under both normal (a) and ischemic conditions (b) 
(n=7~8 per condition). The error bars represent the mean±SEM. ADC, human arginine decarboxylase; NC, normal conditions; OGD 2hr, 2-h oxygen–
glucose deprivation injury. White arrows indicate positive cells.
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(CDK4/6–cyclin D) and the CDK2 complex (CDK2–cyclin E) 
sequentially phosphorylate retinoblastoma protein (pRB), which 
possible to bind the transcription complex E2F-DP1. In an un-
committed cell, hypo-phosphorylated pRB hinder to bind the 
E2F1-DP1 transcription factor in the S phase-specific genes, sug-
gesting that the pRB phosphorylation is essential to enter the G1-S 
transition [31, 32].
In the present study, we carried out immunocytochemistry and 
western blot investigations of CDK4, p-pRB, pRB, and E2F1 in the 
ADC-NPCs (Fig. 3A and 3K). The immunocytochemical staining 
results revealed significant changes in the subcellular localization 
and fluorescence intensity of these cell cycle regulatory proteins 
Fig. 2. Neural progenitor cells (NPCs) overexpressing arginine decarboxylase (ADC) genes (ADC-NPCs) promote neural differentiation following 
ischemic stress. (A) Western blot of NPCs and (B) quantification graph showing the increase in the expression levels of neural marker DCX and oli-
godendroglial marker Olig2, and the decrease in the expression level of astroglial marker GFAP in ADC-NPCs following oxygen–glucose deprivation 
(OGD) (n=5~7 per condition). (C~E) Immunocytochemical staining of the NPCs and quantification graphs showing neural differentiation indicated 
by labelling with: (C) DCX (green) and nestin (red); (D) S100β (green) and GFAP (red); and (E) MBP (green) and Olig2 (red) antibodies. We used 4ʹ,6-
diamidino-2-phenylindole (DAPI) as a nucleus for counterstaining (blue). The error bars represent the mean±SEM. ADC, human arginine decarboxyl-
ase; NC, normal conditions; OGD 2hr, 2-h oxygen–glucose deprivation injury. White arrows indicate positive cells.
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Fig. 3. Neural progenitor cells (NPCs) overexpressing arginine decarboxylase (ADC) genes (ADC-NPCs) accelerate cell cycle exit via aberrant nucleocy-
toplasmic shuttling of phospho-retinoblastoma protein (p-pRB) and E2F1 during ischemic stress. (A) Immunocytochemistry, and correlation analysis (by 
Pearson’s correlation coefficient (PCC)) of CDK4 (B), phospho-retinoblastoma protein (p-pRB) (C), pRB (D), and E2F1 (E). CDK4 accumulated in the nuclei 
of the ADC-NPCs following oxygen–glucose deprivation (OGD) injury (B). p-pRB increased significantly in the ADC-NPCs under normal and OGD con-
ditions (C). However, there were no significant changes in the levels of pRB in the cytoplasmic fractions of the wild-type NPCs (wt-NPCs) and ADC-NPCs 
under normal conditions (D). The levels of E2F1 were significantly reduced in the nuclear fractions of the ADC-NPCs under normal and OGD conditions (E). 
Fluorescence intensity (Manders’ overlap coefficient, MOC) graphs representing CDK4 (F), p-pRB (G), pRB (H), and E2F1 (I) proteins. (J) Representation 
of nucleocytoplasmic shuttling of cell cycle-related components in the ADC-NPCs. (K) Western blot of cytoplasmic and nuclear protein expression. Quanti-
fication graphs of CDK4 (L), p-pRB (M), pRB (N), and E2F1 (O). As with the immunocytochemical staining results, hyperphosphorylated pRB (p-pRB Ser 
807/811) increased significantly in the cytoplasmic fraction of the ADC-NPCs under normal and OGD conditions. However, the levels of E2F1 were signifi-
cantly reduced in the cytoplasmic fraction of the ADC-NPCs under normal and OGD conditions. The error bars represent the mean±SEM.
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(Fig. 3B~3I). We used PCC and MOC to analyze the subcellular 
localization values and fluorescence intensities of CDK4, pRB, 
p-pRB, and E2F1 in the ADC-NPCs using the JACoP plugin in 
ImageJ (Fig. 3B~3E for PCC and Fig. 3F~3I for MOC). CDK4 was 
mainly expressed in the nuclear fractions of both the wt-NPCs 
and ADC-NPCs under normal conditions (r=0.51 and 0.49, re-
spectively) and OGD conditions (r=0.4 and 0.38, respectively); 
the Pearson’s r-values indicate that CDK4 and DAPI were closely 
colocalized (Fig. 3B). The Pearson’s r-values for p-pRB expression 
in the ADC-NPCs under normal and OGD conditions were 0.2 
and 0.14 respectively, which indicates weak colocalization with 
DAPI in the ADC-NPCs. This result indicates that the subcellular 
localization of p-pRB shifted from the nucleus to the cytoplasm 
in the ADC-NPCs under normal and OGD conditions (Fig. 3C). 
However, there were no significant changes in the r-values for 
the expression of pRB (Fig. 3D), and the subcellular localization 
of E2F1 had a similar pattern to p-pRB (Fig. 3E; Pearson’s r=0.2 
and 0.14, respectively). The fluorescence intensity (analyzed by 
MOC) also revealed that the expression levels of CDK4 (Fig. 3F), 
p-pRB (Fig. 3G), pRB (Fig. 3H), and E2F1 (Fig. 3I) proteins were 
significantly increased in the ADC-NPCs following ischemic 
stress. We carried out western blot analysis of the cytoplasmic and 
nuclear fractions of the wt-NPCs and ADC-NPCs to evaluate 
the cytoplasmic and nuclear expression levels of CDK4, p-pRB, 
pRB, and E2F1 (Fig. 3K). The expression of nuclear CDK4 in the 
ADC-NPCs was similar to that in the wt-NPCs under both condi-
tions, but the cytoplasmic expression of CDK4 was slightly higher 
in the ADC-NPCs under normal conditions than under OGD 
conditions (Fig. 3L). The expression of p-pRB (Ser 807/811) was 
significantly higher in the cytoplasmic fraction of the ADC-NPCs 
than in the nuclear fraction under both normal and OGD condi-
tions (Fig. 3M). pRB protein expression increased significantly in 
the cytoplasmic fractions of both the wt-NPCs and ADC-NPCs 
under normal conditions, but they were significantly reduced un-
der OGD conditions (Fig. 3N). E2F1 expression was significantly 
reduced in the cytoplasmic fraction of the ADC-NPCs under 
both normal and OGD conditions (Fig. 3O). These results suggest 
that the overexpression of ADC genes in NPCs regulates cell cycle 
arrest by promoting CDK4-induced pRB phosphorylation and 
inducing the nucleocytoplasmic shuttling of p-pRB and E2F1 fol-
lowing ischemic stress.
ADC-NPCs resist intracellular calcium-induced mitochon-
drial membrane potential collapse following ischemic stress
The overexpression of ADC genes in the NPCs promotes cell 
cycle exit and neural differentiation, but it is not clear which fac-
tors regulate such changes and modifications. Accumulating 
evidence suggests that the increasing level of intracellular Ca2+ 
plays an essential role in the cell cycle, including cell proliferation, 
differentiation, and apoptosis [33]. In the present study, we hy-
pothesized that overexpressed ADC genes elevate the intracellular 
calcium concentration [Ca2+i] in ADC-NPCs following ischemic 
stress. To investigate the changes in [Ca2+i] levels, we stained the 
cells with Fluo-4AM (4 μM) and used time-lapse fluorescence 
imaging (Fig. 4A and 4B). The [Ca2+i] levels increased significantly 
in the ADC-NPCs in both the resting state (without treatment 
or treatment with the negative control (dimethyl sulfoxide): 
117.37±7.38 nM; Fig. 4A) and excitation state (ionomycin treat-
ment: 288.58±26.96 nM; Fig. 4B) compared to [Ca2+i] levels in 
the wt-NPCs following OGD injury (resting: 21.19±0.22 nM and 
excitation: 28.97±1.4 nM). To determine whether these increases 
in [Ca2+i] levels were caused by the overexpression of ADC genes, 
we used small interfering human ADC (siADC, 10 nM; Bioneer, 
Republic of Korea) to interfere with the expression of the ADC 
genes. We transfected siADC into the ADC-NPCs over 3 days, and 
labeled the cells with Fluo-4AM (4 μM) to determine the intracel-
lular [Ca2+i] levels (Fig. 4C and 4D). The excessive [Ca
2+
i] levels 
observed in the resting and excitation states (136.6±0.27 nM and 
505.07±22.49 nM, respectively) were significantly reduced by si-
ADC transfection (86.56±0.19 nM and 311.55±18.19 nM, respec-
tively). These results suggest that the overexpression of ADC genes 
can elevate and regulate intracellular [Ca2+i] levels in NPCs under 
pathological conditions. However, it is well known that excessive 
intracellular [Ca2+i] is a major cause of cellular stress, and induces 
mitochondria-dependent apoptosis [7]. Our previous reports [14, 
16, 20] and the present study have shown that cell death can be 
attenuated in ADC-NPCs following ischemic insults (Fig. 1C and 
1D). Following these results, we investigated the mitochondrial 
cellular metabolism of the ADC-NPCs. We assessed the biologi-
cal profile of the OCR (Fig. 4E) as a mitochondrial function in 
the ADC-NPCs using an XF24 extracellular flux analyzer under 
both normal and pathological conditions (n=7 replicates from two 
independent experiments). Interestingly, we found that the basal 
respiration level of the OCR increased significantly in the ADC-
NPCs under normal conditions (695.56±23.33 pMoles/min/μg) 
compared to the basal respiration levels of the OCR in the wt-
NPCs under normal conditions and in the ADC-NPCs under 
OGD conditions (119.99±37.79 and 434.03±84.78 pMoles/min/
μg, respectively) (Fig. 4F). Assessment of the area under the curve 
of the oxygen consumption rate (OCR-AUC) revealed that the 
mitochondrial ability of the ADC-NPCs at basal respiration (Fig. 
4G), the ATP-linked respiration (Fig. 4H), and the maximal res-
piration (Fig. 4I) were significantly elevated under normal condi-
tions (7840.23±1817.27, 4029.26±1252.83, and 15053.96±4057.87 
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Fig. 4. Neural progenitor cells (NPCs) overexpressing arginine decarboxylase (ADC) genes (ADC-NPCs) accumulate intracellular calcium by regulat-
ing mitochondrial function during ischemic stress. (A) Fluo-4AM-labeled ADC-NPCs were observed by live cell imaging analysis under both normal 
and ischemic conditions; the graph depicts the increased [Ca2+i] levels in the ADC-NPCs in the resting state (Fluo-4AM only). (B) The graph shows the 
higher [Ca2+i] levels in the ADC-NPCs in the excitation state (1 μM ionomycin treatment). (C and D) Small interfering RNA (siRNA)-treated and Fluo-
4AM-labeled ADC-NPCs following oxygen–glucose deprivation (OGD. The graph shows the [Ca2+i] levels in the resting (Fluo-4AM only; C) and exci-
tation (1 μM ionomycin treatment; D) states. (E) The oxygen consumption rate (OCR) principle and (F) the OCR graph; all the NPCs were investigated 
using a Seahorse XF24 Extracellular Flux Analyzer (n=6~7 per condition). (G-I) The graphs depict the analysis of the area under the curve of the oxygen 
consumption rate (OCR-AUC) in the NPCs under normal and ischemic conditions. (G) Basal respiration, (H) ATP-linked respiration, and (I) maximal 
respiration under both normal and ischemic conditions. The error bars represent the mean±SEM.
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pMoles/min, respectively) and under O GD conditions 
(3055.39±583.34, 1266.85±306.65, and 3928.29±778.31 pMoles/
min, respectively). These data suggest that the overexpression of 
ADC significantly increases the mitochondrial membrane poten-
tial (ΔΨm) following ischemic stress (Fig. 4F~4I). Collectively, these 
data suggest that the overexpression of ADC genes plays a pivotal 
role in elevating mitochondrial membrane potential and respira-
tion, and increasing intracellular calcium levels in NPCs following 
ischemic stress.
ADC-NPCs promote neural differentiation via ERK1/2, 
CREB, and STAT1 phosphorylation following ischemic stress
A growing body of evidence suggests that many signaling pro-
teins are related to NPC differentiation, and are also related to 
cellular [Ca2+i] and intracellular ionic changes. CREB, ERK1/2, 
and JAK-STAT signaling are reportedly related to NPC differ-
entiation and calcium homeostasis in cells [34]. Changes to the 
cellular [Ca2+i] level may facilitate the importation of phosphory-
lated STAT into the nucleus to induce maximal transcriptional 
activation, which is also accompanied by the phosphorylation of 
ERK1/2 (Thr202/Tyr204), and CREB (Ser133) in NPCs [35-38]. 
In the present study, we investigated changes in the phosphorylat-
ed protein levels and the cellular localization of pERK1/2, pCREB, 
and pSTAT1 in the ADC-NPCs. The immunocytochemical stain-
ing results showed that cytoplasmic pERK1/2, and nuclear pCREB 
and pSTAT1 proteins were highly expressed in the ADC-NPCs 
under both normal and ischemic conditions (Fig. 5A). The cellular 
localizations of pERK1/2 (Fig. 5B), pCREB (Fig. 5C), and pSTAT1 
(Fig. 5D) (analyzed by PCC) were determined from the immu-
nocytochemical staining of the wt-NPCs and ADC-NPCs under 
both normal and ischemic conditions. Interestingly, the Pearson’s 
r-value for pERK1/2 expression was zero (r=0), which implies 
there was no correlation with DAPI in the ADC-NPCs following 
OGD injury. This result suggests that pERK1/2 expression was sig-
nificant in the cytoplasm of the ADC-NPCs under OGD condi-
tions. Moreover, the Pearson’s r-value for pSTAT1 expression was 
r=0.8 in the ADC-NPCs following OGD injury, which means that 
pSTAT1 was highly colocalized with DAPI, suggesting that there 
is a significant accumulation of pSTAT1 in the nuclei of the ADC-
NPCs during ischemic stress (Fig. 5F and 5G). The fluorescence 
intensity (analyzed by MOC) indicated that the expression levels 
of pERK1/2 (Fig. 5E), pCREB (Fig. 5F), and pSTAT1 (Fig. 5G) 
proteins increased significantly in the ADC-NPCs under both 
normal and ischemic conditions. The results of western blot analy-
sis corroborated those from the immunocytochemical staining of 
the wt-NPCs and ADC-NPCs (Fig. 5H~5N). The quantification 
of the western blot data for the ADC-NPCs showed significantly 
higher expression levels of cytoplasmic pERK1/2, nuclear pCREB, 
and pSTAT1 under ischemic conditions. In summary, the results 
of the in vitro study suggest that ADC-NPCs attenuate cell death 
(Fig. 1), promote neural differentiation (Fig. 2), and modulate 
cell cycle exit (Fig. 3) by accumulating intracellular calcium (Fig. 
4), and regulate the expression levels of cytoplasmic and nuclear 
pERK1/2, pCREB, and pSTAT1 proteins (Fig. 5) following isch-
emic stress.
ADC-NPCs have a therapeutic role in transient cerebral 
ischemia
To determine the therapeutic potential of ADC-NPCs in the 
CNS, we injected ADC-NPCs into the brain of an adult rat follow-
ing cerebral ischemic injury, and determined the infarct volume, 
neurological functional recovery, neuronal differentiation, and 
synapse formation. The ADC-NPCs were transplanted into the rat 
brain 7 days after MCAO, and had significantly reduced the brain 
infarct volume by Days 14 and 28 after MCAO (Fig. 6A). Motor 
function had increased significantly by Day 14 after MCAO in the 
ADC-NPC-transplanted groups compared to the experimental 
control (EC) and wt-NPCs groups, and continued to increase 
until Day 28 after MCAO (Fig. 6B). The immunohistochemical 
staining of the ADC-NPC-transplanted rats revealed marked 
increases in the expression levels of the mature neuron marker 
MAP2+ both in and beyond the peri-infarct areas by Day 14 after 
MCAO, compared to the EC- and normal NPC-transplanted rats 
(Fig. 6C). The levels of the synaptic molecules synaptophysin and 
PSD95, levels of the neuronal marker GAP43, and the number of 
neurofilaments increased in the ADC-NPC-transplanted groups 
(Fig. 6D~6H). The colocalization of synaptophysin and PSD95 in 
the MAP2-positive cells and the number of synaptophysin puncta 
also increased significantly in the ADC-NPC-transplanted groups 
(Fig. 6I and 6J). Collectively, the results demonstrate that the 
transplanted ADC-NPCs can attenuate infarct volume, promote 
neural differentiation, and enhance motor function recovery, and 
the synapse formation and transplantation of ADC-NPCs sug-
gests their potential as the basis of a stem cell therapy for cerebral 
ischemic injury.
DISCUSSION
Cell replacement therapy using NPCs could become a popular 
option for treating ischemic brain injury. However, transplanted 
NPCs often encounter harsh environmental conditions in the 
ischemic brain, and it is difficult to control their fate. In the pres-
ent study, we identified the cellular characteristics of NPCs over-
expressing ADC genes (ADC-NPCs) during ischemic stress. Cell 
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Fig. 5. Neural progenitor cells (NPCs) overexpressing arginine decarboxylase (ADC) genes (ADC-NPCs) promote neurogenesis via ERK1/2, CREB, 
and STAT1 phosphorylation during ischemic stress. (A) Immunocytochemistry of pERK1/2, pCREB, and pSTAT1 in the NPCs under both normal and 
oxygen–glucose deprivation (OGD) conditions. Colocalization analysis graphs (using Pearson’s coefficient) for p-ERK1/2 (B), pCREB (C), and pSTAT1 
(D). The fluorescence intensity graphs (analyzed using Manders’ overlap coefficient) represent p-ERK1/2 (E), pCREB (F), and pSTAT1 (G) proteins. (E) 
The western blot analysis of nuclear and cytoplasmic fractions of the NPCs with an anti-pERK1/2, pCREB, and pSTAT1 proteins supports the immuno-
cytochemical staining results under normal and OGD conditions. The western blot data were quantified in the nuclear and cytoplasmic fractions of the 
NPCs with an anti-pERK1/2 (I), ERK1/2 (J), pCREB (K), CREB (L), pSTAT1 (M), and STAT1 (N) under normal and OGD conditions. The error bars 
represent the mean±SEM.
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Fig. 6. Transplanted neural progenitor cells (NPCs) overexpressing arginine decarboxylase (ADC) genes (ADC-NPCs) attenuate infarct volume and 
promote motor function following middle cerebral artery occlusion (MCAO). (A) Infarct volume analysis by hematoxylin and eosin (H&E) staining. 
The graph summarizes the significant changes in the transplanted ADC-NPCs following cerebral ischemia. (B) Rotarod test conducted 7~28 days after 
MCAO. The graph represents neurological motor function recovery following cerebral ischemia (n=12 per condition). (C) Immunocytochemical stain-
ing of MAP2 protein in the ipsilateral striatum 14 days after MCAO. (D) Immunoblotting of the neural differentiation- and synapse formation-related 
proteins in the ipsilateral striatum 14 days after MCAO. (E-H) Quantification graphs of immunoblotting summarizing the expression levels of synapse 
formation-related proteins, normalized to the control. (I) High-magnification image of the results of immunocytochemical staining showing MAP2 
(white)/synaptophysin (red)/PSD95 (green)-positive cells in the ipsilateral striatum 14 days after MCAO. (J) Quantification graph of the number of syn-
aptophysin puncta in the ipsilateral striatum 14 days after MCAO. EC, experimental control; NPCs, transplanted neural stem cells; ADC-NPCs, neural 
progenitor cells (NPCs) overexpressing arginine decarboxylase (ADC) genes. Yellow arrows indicate colocalized synaptophysin puncta and PSD95 in 
the MAP2-positive cells. The error bars represent the mean±SEM.
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death was significantly reduced in the ADC-NPCs, and prolifera-
tion potential was suppressed by intracellular Ca2+-induced CDK4 
activation and nucleocytoplasmic shuttling of p-pRB and E2F1 
in the ADC-NPCs following OGD injury. Moreover, the ADC-
NPCs were attenuated by excessive cytosolic Ca2+-induced mito-
chondrial dysfunction and cell death following ischemic stress. 
Consequently, molecular cascades in the ADC-NPCs promoted 
neuronal differentiation by enhancing pSTAT1 (ser727) expres-
sion via Ca2+-related ERK1/2 and CREB phosphorylation. The 
transplantation of these ADC-NPCs promoted synapse formation 
and motor function recovery following cerebral ischemia. There-
fore, our study provides the basis for a novel cell replacement 
therapy for ischemic stroke using ADC-NPCs that could attenuate 
excessive calcium tolerance, mitochondrial dysfunction, and be-
havior retardation.
Previously it was reported that the arginine decarboxylase (ADC) 
is a part of the acid-resistance (AR) system in the several organ-
isms such as Escherichia coli  and plants, stress-induced gene ex-
pression in the organisms. The ADC can act in the process of the 
decarboxylation of L-arginine to agmatine. The ADC is predicted 
to be an inner membrane antiporter which regulates the system 
by exchanging the external substrate essential for the cytoplasmic 
products in the extreme acidic stress condition [39-43]. In addi-
tion, there are several reports that overexpressed ADC genes can 
reduce oxidative stress in mammalian NSCs following ischemic 
stress [14, 16]. In this study, we confirmed that the exogenously 
transfected by retrovirus delivery vehicle containing human ADC 
gene is efficiently introduced stable, heritable genetic material into 
the host genome of neural stem cells and mesenchymal stem cells 
[14, 20]. We also confirmed that the endogenous ADC expression 
is increased in the wild-type cells and normal brain tissue in the 
previous study [14, 20, 44, 45] and the present study. Nevertheless, 
in the further increase of ADC expression after ischemic injury, it 
is difficult to differentiate between the effect of ADC gene delivery 
and the endogenous increase in response to stress. Following these 
results suggest that the endogenous and exogenous ADC gene 
was promoted by the injury-specific gene condition in NPCs. In 
the present study, the levels of both ADC protein expression and 
agmatine were significantly upregulated in the ADC-NPCs, and 
were negatively correlated with the dead cell marker PI-labeled 
cells during ischemic conditions.
The short-term OGD exposure induces the neural differentia-
tion of NPCs while maintaining cell survival [46, 47]. The expres-
sion of neuronal differentiation marker DCX and oligodendrog-
lial marker Olig2 were increased, but the expression of astrocyte 
marker GFAP was reduced in the ADC-NPCs following ischemic 
stress. One of the candidate neural differentiation and glial inhibi-
tory mechanism is BMP signaling. BMPs are known to regulate 
proliferation or differentiation of neurons, oligodendrocytes, and 
astrocytes during CNS development [48]. Previous our study 
suggests that ADC expression and agmatine treatment reduced 
collagen scar formation and functional outcome may due to in-
creased tissue preservation within the injury site in SCI mice [19, 
49]. In particular, BMP4 enhanced the astrocytic lineage during 
CNS development and contributed to the formation of glial scar 
in injured spinal cord [50, 51]. Following these previous reports 
suggesting that the reduction of differentiation to astrocytes in 
ADC-NPCs is expected to lead to a decrease in glial scar forma-
tion following cerebral ischemic injury, and increased differentia-
tion into neurons and oligodendrocytes in ADC-NPCs will also 
lead to axonal regeneration and functional recovery. It has also 
shown that exogenously administered agmatine to SVZ-NSC cells 
increases neuronal differentiation but decreases astrogenesis [52]. 
It has reported that this neurogesis effect of agmatine seem to be 
related to the extracellular signal-regulated kinase (ERK1/2) ac-
tivation, and the anti-astrogenesis effect is related to inhibition of 
bone morphogenetic proteins (BMPs) [52]. In addition, Marchal 
et al. [53] and Leclerc [54-56] et al. provide with intriguing clues as 
to the relationship among BMP signal blocking, FGF signaling and 
calcium signaling in neuroectodermal differentiation. The BMP 
signal blocking is responsible to the neuroectodermal differentia-
tion by calcium signaling [57]. Although this study did not show 
a direct correlation between increased calcium concentration and 
BMP signaling in ADC-NPCs, based on the results of this study 
and previous research reports, we might suggest that neural and 
glial differentiation in ADC-NPCs is regulated through BMP and 
calcium signaling.
Calcium acts as a pleiotropic second messenger that triggers 
numerous physiological processes such as cell proliferation, dif-
ferentiation, and cell death [58, 59]. CDKs, pRB, and E2F1 are 
well-known transcriptional regulators that determine cell cycle 
progression during the G1-S phase transition [60]. Hypophos-
phorylated pRB recognizes E2F-DP complexes, which act as 
tumor suppressors by inhibiting the G1-S phase checkpoint and 
controlling differentiation and apoptosis [61, 62]. Mammalian cells 
contain various CDKs and cyclins, and oscillations in the expres-
sion and activity of these cell cycle molecules are regulated during 
cell division [63, 64]. During cell cycle progression, Ca2+ assembles 
and activates the cyclinD-CDK4 and cyclinE-CDK2 complexes. 
Later in the G1 phase, Ca2+ ensures the phosphorylation of reti-
noblastoma protein (p-pRB) in the nucleus and entry into the S 
phase. Moreover, calmodulin-induced CDK4 activation regulates 
the nuclear export of phosphorylated pRB in mouse embryo fi-
broblasts [65], and E2F1 induces nucleocytoplasmic shuttling in 
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high Ca2+ conditions in mouse keratinocytes. Endogenous E2F1 
is substantially downregulated during differentiation [66, 67]. The 
results of the present study suggest that overexpressed ADC genes 
in ADC-NPCs promote higher levels of p-pRB and suppress E2F1 
expression in the cytoplasmic fraction, which might terminate 
the cell cycle and initiate cellular differentiation. The reason for 
the higher p-pRB expression in the cytoplasm of the ADC-NPCs 
requires further investigation. One of the possible explanations for 
this phenomenon is the regulation of cytosolic calcium ions (Ca2+), 
which reportedly control the cell cycle via a Ca2+/calmodulin 
(CaM) complex that regulates the expression of cell cycle mol-
ecules such as CDKs [59, 63, 68, 69]. Ca2+ is a ubiquitous second-
ary messenger that is involved in the regulation of many cellular 
activities. Importantly, both cytosolic and nuclear Ca2+ levels play 
essential roles in cell cycle progression, cell proliferation, differen-
tiation, and apoptosis [33]. Moreover, one of the many roles of Ca2+ 
is as a key regulator of mitochondrial function that controls ATP 
synthesis. However, the dysregulation of Ca2+ homeostasis leads to 
the enhanced generation of ROS, triggering the opening of mito-
chondrial permeability transition pores (MPTPs) and cytochrome 
c release leading to apoptosis [70]. According to previous studies, 
the metabolite of ADC, agmatine, has a scavenging effect on toxic 
ROS by protecting against a drop in energy capacity, Ca2+-induced 
mitochondrial swelling, Ca2+-dependent induction of mitochon-
drial permeability, and mitochondrial membrane potential (ΔΨm) 
collapse in rat brain and rat kidney mitochondria [12, 13]. Our re-
sults indicate that the level of cellular Ca2+ was upregulated in the 
ADC-NPCs during OGD. This increase in cellular Ca2+ was sup-
pressed by ADC-specific siRNA transfection, and it was evident 
that the increase in the Ca2+ levels in the ADC-NPCs was caused 
by the overexpression of ADC genes. However, the accumula-
tion of intracellular calcium in the cytosol of the ADC-NPCs was 
not accompanied by mitochondrial dysfunction owing to ROS 
scavenging in the presence of endogenous agmatine production. 
In the present study, the mitochondrial OCR in the wt-NPCs was 
significantly reduced the mitochondrial respiration rates, ATP 
synthesis and accompanied with cell death. But, the mitochondrial 
OCR in the ADC-NPCs was significantly higher during the basal 
mitochondrial respiration, ATP-linked respiration, and maximal 
respiration under both normal and OGD conditions. Therefore, 
we suggest that overexpressed ADC genes in ADC-NPCs might 
play a vital role in strengthening intracellular calcium resistance 
and preventing mitochondrial membrane potential collapse fol-
lowing ischemic injury.
Phosphorylation of the transcriptional factor STAT1/3 plays an 
important role in the CNS during neuroglial differentiation [34, 
71, 72]. Previous reports suggest that STAT1 can become phos-
phorylated in response to cellular stress involving elevated ERK 
and [Ca2+i] levels [73-75]. Furthermore, Takagi et al. reported that 
STAT1 phosphorylation at Tyr701 and Ser727 (pSTAT1), nuclear 
translocation, and DNA binding can be promoted within hours 
of cerebral ischemia [76]. Phosphorylated ERK1/2 is involved 
in regulating STAT1/3 function [36]. Phosphorylated CREB is 
usually absent in adult stem cells, and is transiently upregulated 
in NPCs in the differentiation state [77]. CREB phosphorylated 
at Ser133 (pCREB) is involved in regulating various signaling 
pathways triggered by a variety of factors that cause cellular stress, 
including H2O2 exposure, UV light, inflammatory cytokines, and 
growth factors [78, 79]. The loss of CREB signaling results in cell 
death and the loss of neuronal gene expression [80]. These mul-
tiple roles of CREB may be controlled by the phosphorylation of 
Ca2+/calmodulin-dependent protein kinases (CaMKs). Our study 
revealed a significant increase in the level of pSTAT1 protein fol-
lowing ERK1/2 and CREB phosphorylation in the ADC-NPCs 
after ischemic injury. pCREB phosphorylated at Ser133 promotes 
transcriptional activity and interacts with NGN1, forming the 
CREB-binding protein (CBP)/P300-pSTAT1/3 complex. pSTAT1 
could increase the transcriptional activities of neuronal-specific 
genes (e.g., NGN, DCX, Olig2), and the CBP/P300 component of 
this complex is recognized by the bHLH DNA-binding motif of 
the proneural gene of an E-box site via a bZIP transcriptional fac-
tor, binding to neurogenin1 and neurogenin2 [81, 82]. Besides, the 
treatment of ischemic stroke by cell replacement therapy involves 
checking tissue and cellular damage, neuroglial replacement to 
restructure neuronal connectivity and conduction, and the provi-
sion of a favorable tropic environment around the ischemic area 
[83, 84]. In our previous study, it has reported that ADC-MSCs 
promote locomotor function after SCI by increasing BDNF level, 
which has been associated with neuronal survival and replace-
ment of damaged neurons in SCI and exerts a paracrine effect. 
This finding may elucidate the paracrine effects of BDNF as key 
roles in the therapeutic effects on the neuronal regeneration, oligo-
dendrogenesis, inhibition of glial scar formation, improved motor 
function recovery in ADC-transfected cells following CNS injury 
[19]. Based on the previous studies, even we did not confirm the 
BDNF level in the ADC-NPCs transplantation after cerebral isch-
emia, it is possible that the ADC-NPCs has therapeutic effects via 
BDNF expression, and activates neural differentiation through the 
BDNF-induced phosphorylation of pCREB/pSTAT1 after CNS 
injury.
The transplantation of ADC-NPCs reduced the infarct volume 
compared to the transplantation of wt-NPCs following transient 
cerebral ischemic injury. Motor function was also markedly re-
stored in the rats that had received ADC-NPC transplantation 
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compared to those that had not. Moreover, there was greater neu-
ral differentiation and neuronal fiber formation, and the number 
of synaptophysin puncta increased significantly in the peri-infarct 
region of the ADC-NPC groups following cerebral ischemia. 
In the present study, the protein expression of synaptophysin, 
GAP43, PSD95, and neurofilament were significantly increased 
in the ipsilateral brain transplanted ADC-NPCs at 14 days after 
MCAO. The GAP43 is nervous system-specific protein, is highly 
expressed neuronal growth cones during neurogenesis [85]. The 
GAP43 expression was highly correlated with synaptophysin, 
PSD95, and neurofilament in the transplanted ADC-NPCs group. 
However, we have some limitation about this study, which is iden-
tified the origin of the cells in the ipsilateral brain. We were used 
BrdU incorporation for in vitro pre-labeling of transplanted cells 
in order to track these cells in the recipient animals. However, 
the long-term approaches of BrdU-labeling may give rise to false 
negative results leading to an underestimation of cell proliferation 
including neurogenesis [86]. In our results showed that BrdU-sig-
nal were time-dependently decreased and diffused from nucleus 
to cytoplasm in the ipsilateral striatum (Data not shown). This 
condition was difficult to identify and estimate the proportions of 
neural characteristics in transplanted cells or resident cells. There-
fore, we focused on the only a therapeutic potentials of ADC-
NPCs as CNS therapeutics after ischemic stroke.
In conclusion, we have reported the therapeutic potential of 
ADC-NPCs, which promote cell cycle exit and neural differen-
tiation by elevating [Ca2+i]-induced CDK4 activation, nucleocy-
toplasmic shuttling of pRB-E2F1, and nuclear translocation of 
pSTAT1 following ischemic stress. Moreover, the excessive intra-
cellular calcium-induced mitochondrial membrane potential col-
lapse following ischemic stress was prevented in the ADC-NPCs. 
Transplanted ADC-NPC promoted neurological functional 
recovery following ischemic stroke. This may have been owing to 
neural differentiation and synapse formation in a favorable envi-
ronment. The present study indicates that the overexpression of 
ADC genes in ADC-NPCs could form the basis of a promising 
cell replacement therapy.
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